Literature DB >> 28597118

CORR Insights®: Prolotherapy Induces an Inflammatory Response in Human Tenocytes In Vitro.

Benjamin K Potter1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28597118      PMCID： PMC5498400          DOI： 10.1007/s11999-017-5407-5

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN： 0009-921X            Impact factor:   4.176


× No keyword cloud information.
  6 in total

1.  Editorial: Getting Evidence Into Practice--or Not: The Case of Viscosupplementation.

Authors:  Seth S Leopold
Journal:  Clin Orthop Relat Res       Date:  2015-11-16       Impact factor: 4.176

2.  Bench to Bedside: Platelet-rich Plasma-How Do We Adequately "Untranslate" Translational "Breakthroughs" in an After-market Setting?

Authors:  Benjamin K Potter
Journal:  Clin Orthop Relat Res       Date:  2016-07-22       Impact factor: 4.176

Review 3.  Comparative effectiveness of injection therapies in lateral epicondylitis: a systematic review and network meta-analysis of randomized controlled trials.

Authors:  Thøger Persson Krogh; Else Marie Bartels; Torkell Ellingsen; Kristian Stengaard-Pedersen; Rachelle Buchbinder; Ulrich Fredberg; Henning Bliddal; Robin Christensen
Journal:  Am J Sports Med       Date:  2012-09-12       Impact factor: 6.202

Review 4.  The role of animal models in tendon research.

Authors:  M W Hast; A Zuskov; L J Soslowsky
Journal:  Bone Joint Res       Date:  2014-06       Impact factor: 5.853

5.  Effectiveness and safety of prolotherapy injections for management of lower limb tendinopathy and fasciopathy: a systematic review.

Authors:  Lane M Sanderson; Alan Bryant
Journal:  J Foot Ankle Res       Date:  2015-10-20       Impact factor: 2.303

Review 6.  Hypertonic dextrose injections (prolotherapy) in the treatment of symptomatic knee osteoarthritis: A systematic review and meta-analysis.

Authors:  Regina Ws Sit; Vincent Ch Chung; Kenneth D Reeves; David Rabago; Keith Kw Chan; Dicken Cc Chan; Xinyin Wu; Robin St Ho; Samuel Ys Wong
Journal:  Sci Rep       Date:  2016-05-05       Impact factor: 4.379
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.